KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Current Taxes (2018 - 2025)

Adaptive Biotechnologies' Current Taxes history spans 8 years, with the latest figure at $541000.0 for Q4 2025.

  • For Q4 2025, Current Taxes rose 207.39% year-over-year to $541000.0; the TTM value through Dec 2025 reached $541000.0, up 207.39%, while the annual FY2025 figure was $541000.0, 207.39% up from the prior year.
  • Current Taxes for Q4 2025 was $541000.0 at Adaptive Biotechnologies, up from $176000.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $541000.0 in Q4 2025 and bottomed at $59000.0 in Q4 2023.
  • The 5-year median for Current Taxes is $194000.0 (2022), against an average of $272200.0.
  • The largest annual shift saw Current Taxes plummeted 77.87% in 2021 before it skyrocketed 207.39% in 2025.
  • A 5-year view of Current Taxes shows it stood at $391000.0 in 2021, then crashed by 50.38% to $194000.0 in 2022, then plummeted by 69.59% to $59000.0 in 2023, then soared by 198.31% to $176000.0 in 2024, then surged by 207.39% to $541000.0 in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Current Taxes are $541000.0 (Q4 2025), $176000.0 (Q4 2024), and $59000.0 (Q4 2023).